FDA approves first treatment for smoldering multiple myeloma - PubMed
8 hours ago
- #FDA
- #multiple myeloma
- #daratumumab
- FDA approves first treatment for smoldering multiple myeloma.
- The approved treatment is daratumumab and hyaluronidase‐fihj for high‐risk smoldering multiple myeloma.
- Approval was announced on November 6, 2025.
- A study published in the New England Journal of Medicine supports the use of daratumumab for high-risk smoldering multiple myeloma.